{"id":256395,"date":"2015-01-15T12:49:16","date_gmt":"2015-01-15T17:49:16","guid":{"rendered":"http:\/\/www.eugenesis.com\/nobel-laureate-martin-chalfie-to-address-international-nanomedicine-conference\/"},"modified":"2015-01-15T12:49:16","modified_gmt":"2015-01-15T17:49:16","slug":"nobel-laureate-martin-chalfie-to-address-international-nanomedicine-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/nobel-laureate-martin-chalfie-to-address-international-nanomedicine-conference.php","title":{"rendered":"Nobel Laureate Martin Chalfie to Address International Nanomedicine Conference"},"content":{"rendered":"<p><p>Contact Information         <\/p>\n<p>      Available for logged-in reporters only    <\/p>\n<p>    Newswise  LOS ANGELES (Jan. 14, 2015)  Nobel laureate Martin    Chalfie, PhD, will be the keynote speaker at Cedars-Sinais Nanomedicine for Imaging and    Treatment Conference, where two dozen experts from around the    world will discuss emerging trends in the study and treatment    of diseases at the molecular and atomic levels.  <\/p>\n<p>    The March 13-14 event will bring together academic researchers,    clinicians, representatives from the National Institutes of    Health and scientists from private biotech industries to    present lectures and abstracts about advances in nanomedicine    and the development of imaging and drugs in this specialized    field.  <\/p>\n<p>    This conference will give many top scientists and physicians    an opportunity to share insights as the field of nanomedicine    matures and we home in on new ways to diagnose, treat and cure    diseases, said Keith Black, MD, chair and professor of    Cedars-Sinais Department of Neurosurgery.  <\/p>\n<p>    Chalfie, chair of the Department of Biological Sciences at    Columbia University, received the 2008 Nobel Prize in Chemistry    for his part in the discovery and development of green    fluorescent protein, found in a species of jellyfish. The    protein glows when excited by light. Because it can be attached    to many biological substances to make them readily visible, it    has become a fundamental tool in a wide range of medical and    scientific fields.  <\/p>\n<p>    This years program will focus on three issues:    Nanomedicine and imaging: How far are we from patient    care?    Latest preclinical and clinical advances in the treatment of    cancer, neurodegenerative disorders and other pathological    conditions.    The role of the National Institutes of Health in nanodrug and    nano-imaging development.  <\/p>\n<p>    The conference also will address issues relevant to the biotech    industry and the legal profession.    Speakers and presenters will discuss research taking place at    Cedars-Sinai; the California Institute of Technology; Harvard    Medical School; Houston Methodist Hospital; the Massachusetts    Institute of Technology; Max Planck Institute of Biophysical    Chemistry, Germany; the National Cancer Institute; the National    Institutes of Health; Northeastern University; Rutgers, The    State University of New Jersey; Saarland University, Germany;    Stanford University; UCLA; the University of Central Florida;    the University of Chicago; the University of New Mexico; the    University of North Carolina, Chapel Hill; the University of    Southern California; and the University of Utah, Salt Lake    City.  <\/p>\n<p>    Nanomedicine is conducted at microscopic levels  at a scale of    about one to 100 nanometers. A nanometer is equal to one    billionth of a meter. A sheet of paper is about 100,000    nanometers thick.  <\/p>\n<p>    Julia Ljubimova, MD, PhD, the nanomedicine    conferences leading organizer, has worked with colleagues at    Cedars-Sinai and UCLA to develop an experimental nanodrug  20    to 30 nanometers in size  to deliver antitumor therapies to    brain and breast cancers. Ljubimova, professor of neurosurgery    and biomedical sciences, is director of the Nanomedicine Research Center in the    Department of Neurosurgery and director of    the Nanomedicine Program at the Samuel Oschin Comprehensive Cancer    Institute.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.newswise.com\/articles\/view\/628372\/?sc=rsmn\/RK=0\/RS=sihlrjjo5u1wIdw0VgI3jT7LQzw-\" title=\"Nobel Laureate Martin Chalfie to Address International Nanomedicine Conference\">Nobel Laureate Martin Chalfie to Address International Nanomedicine Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Contact Information Available for logged-in reporters only Newswise LOS ANGELES (Jan. 14, 2015) Nobel laureate Martin Chalfie, PhD, will be the keynote speaker at Cedars-Sinais Nanomedicine for Imaging and Treatment Conference, where two dozen experts from around the world will discuss emerging trends in the study and treatment of diseases at the molecular and atomic levels. The March 13-14 event will bring together academic researchers, clinicians, representatives from the National Institutes of Health and scientists from private biotech industries to present lectures and abstracts about advances in nanomedicine and the development of imaging and drugs in this specialized field <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/nobel-laureate-martin-chalfie-to-address-international-nanomedicine-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577779],"tags":[],"class_list":["post-256395","post","type-post","status-publish","format-standard","hentry","category-nanomedicine-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256395"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=256395"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=256395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=256395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=256395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}